Answers are grounded in this paper and cite their sources.
Study generates isogenic iPSC lines for myotonic dystrophy type 1, highlighting gene editing implications.
An expanded CTG repeat in the Dystrophia Myotonica Protein Kinase ( DMPK ) gene is associated with myotonic dystrophy type 1 (DM1), an autosomal dominant neuromuscular disorder characterised by progressive muscle weakness, myotonia, cognitive decline, and a variety of other manifestations. Here, we report the generation of isogenic induced pluripotent stem cell (iPSC) lines, derived from patient DM1 iPSC lines carrying varying expanded (CTG) n repeats in DMPK . These gene-edited isogenic iPSC lines, in which the pathogenic repeat has been excised, serve as a reference for assessing DM1-associated phenotypes in relevant differentiated cell types, such as muscle progenitor cells and neurons.
No takes yet. Share an insight, caveat, or question.
Rahm et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: